Boise, IDNCT04739072Now EnrollingIRB Ready

Colorectal Adenocarcinoma Clinical Trial in Boise, ID

Access cutting-edge colorectal adenocarcinoma treatment through this clinical trial at a research site in Boise. Study-provided care at no cost to qualified participants.

Sponsored by M.D. Anderson Cancer Center

Quick Self-Assessment

See if you qualify for this Boise location

Preparing your pre-screening questions…

Expert Care in Boise

Access colorectal adenocarcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related colorectal adenocarcinoma treatment provided free

Apply for This Boise Location

Check if you qualify for this colorectal adenocarcinoma clinical trial in Boise, ID

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boise

    Convenient for ID residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boise site if eligible
  4. 4Begin participation

About This Colorectal Adenocarcinoma Study in Boise

This study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come back or spread. Tumors shed DNA and other cancer related chemicals into the blood that can be identified and studied further to provide information about the cancer. Information gathered from this study may help researchers better understand if ctDNA found in the blood can predict whether colorectal cancer may come back or spread.

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

Age ≥ 18 years.
Histological/cytological confirmation of colorectal adenocarcinoma.
Patients with any stage colorectal adenocarcinoma deemed potentially eligible for curative intent treatment. Patients with stages II-IV colorectal cancer post-R0 resection may also be enrolled onto the protocol any time before or up to 3 months post-surgery and prior to initiating adjuvant therapy.
Ability to understand and the willingness to sign a written informed consent document.
Willing to pursue standard of care surveillance post completion of curative therapies.
Willing to provide blood samples for correlative research.

Exclusion Criteria

Known active malignancies other than colorectal adenocarcinoma that may interfere with detection and / or interpretation of circulating plasma markers. Patients with known clonal hematopoiesis of indeterminate potential are eligible.
Co-morbid systemic illnesses or other severe concurrent disease which, in the judgment of the investigator, would make the patient inappropriate for entry into this study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boise?

Yes, this clinical trial (NCT04739072) has an active research site in Boise, ID that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colorectal Adenocarcinoma Treatment Options in Boise, ID

If you're searching for colorectal adenocarcinoma treatment options in Boise, ID, this clinical trial (NCT04739072) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boise research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal adenocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all colorectal adenocarcinoma clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Boise, ID

See all alzheimers disease clinical trials recruiting in Boise — not just this study.

Browse Alzheimers Disease Trials in Boise

Ready to Join in Boise?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boise, ID